144 related articles for article (PubMed ID: 38159955)
1. Trends in liver cancer mortality in China from 1990 to 2019: a systematic analysis based on the Global Burden of Disease Study 2019.
Chen T; Zhang Y; Liu J; Rao Z; Wang M; Shen H; Zeng S
BMJ Open; 2023 Dec; 13(12):e074348. PubMed ID: 38159955
[TBL] [Abstract][Full Text] [Related]
2. Trends in mortality of liver disease due to hepatitis B in China from 1990 to 2019: findings from the Global Burden of Disease Study.
Cao G; Liu J; Liu M
Chin Med J (Engl); 2022 Sep; 135(17):2049-2055. PubMed ID: 36228164
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
4. Disease burden of liver cancer in China from 1997 to 2016: an observational study based on the Global Burden of Diseases.
Ding C; Fu X; Zhou Y; Liu X; Wu J; Huang C; Deng M; Li Y; Li L; Yang S
BMJ Open; 2019 Apr; 9(4):e025613. PubMed ID: 31015269
[TBL] [Abstract][Full Text] [Related]
5. Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019.
Zhang Y; Liu J; Han X; Jiang H; Zhang L; Hu J; Shi L; Li J
Front Public Health; 2022; 10():994619. PubMed ID: 36159285
[TBL] [Abstract][Full Text] [Related]
6. Global, Regional, and National Trends in Incidence and Mortality of Primary Liver Cancer and Its Underlying Etiologies from 1990 to 2019: Results from the Global Burden of Disease Study 2019.
Cao G; Liu J; Liu M
J Epidemiol Glob Health; 2023 Jun; 13(2):344-360. PubMed ID: 37178451
[TBL] [Abstract][Full Text] [Related]
7. The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management.
Li Y; Ou Z; Yu D; He H; Zheng L; Chen J; Chen C; Xiong H; Chen Q
BMC Cancer; 2023 Jun; 23(1):598. PubMed ID: 37380957
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus/acquired immunodeficiency syndrome prevalence, incidence, and mortality in China, 1990 to 2017: a secondary analysis of the Global Burden of Disease Study 2017 data.
Liu XJ; McGoogan JM; Wu ZY
Chin Med J (Engl); 2021 Apr; 134(10):1175-1180. PubMed ID: 33883410
[TBL] [Abstract][Full Text] [Related]
9. [Burden of hepatitis B-associated diseases in China from 1990 to 2030].
Yao L; Lin S; Huang J; Wu Y
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Nov; 35(5):464-475. PubMed ID: 38148535
[TBL] [Abstract][Full Text] [Related]
10. [Disease burden of liver cancer in China: an updated and integrated analysis on multi-data source evidence].
Cao MD; Wang H; Shi JF; Bai FZ; Cao MM; Wang YT; Yan XX; Wang L; Huang Z; Ren JS; Zhao JJ; Dai M; Qu CF; Chen WQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Nov; 41(11):1848-1858. PubMed ID: 33297650
[No Abstract] [Full Text] [Related]
11. Long-term liver cancer incidence and mortality trends in the Changning District of Shanghai, China.
Ji XW; Jiang Y; Wu H; Zhou P; Tan YT; Li HL; Zhang L; Zhao WS; Xia QH; Bray F; Xiang YB
J Dig Dis; 2020 Apr; 21(4):230-236. PubMed ID: 32124559
[TBL] [Abstract][Full Text] [Related]
12. Changing trends in the disease burden of primary liver cancer caused by specific etiologies in China.
Liu Z; Mao X; Jiang Y; Cai N; Jin L; Zhang T; Chen X
Cancer Med; 2019 Sep; 8(12):5787-5799. PubMed ID: 31385465
[TBL] [Abstract][Full Text] [Related]
13. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD.
Paik JM; Golabi P; Younossi Y; Mishra A; Younossi ZM
Hepatology; 2020 Nov; 72(5):1605-1616. PubMed ID: 32043613
[TBL] [Abstract][Full Text] [Related]
14. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention.
Liu Z; Jiang Y; Yuan H; Fang Q; Cai N; Suo C; Jin L; Zhang T; Chen X
J Hepatol; 2019 Apr; 70(4):674-683. PubMed ID: 30543829
[TBL] [Abstract][Full Text] [Related]
15. [Analysis on incidence trend of liver cancer in China, 2005-2016].
Shi TT; Liu ZQ; Fan H; Zhang PY; Yu SZ; Zhang TJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Mar; 43(3):330-335. PubMed ID: 35345286
[No Abstract] [Full Text] [Related]
16. Comparison of time trends in the incidence of primary liver cancer between China and the United States: an age-period-cohort analysis of the Global Burden of Disease 2019.
Zou Z; Zhang Z; Lu C; Wang H
Chin Med J (Engl); 2022 Sep; 135(17):2035-2042. PubMed ID: 36103990
[TBL] [Abstract][Full Text] [Related]
17. Global, regional, and national burden of lung cancer and its attributable risk factors, 1990 to 2017.
Wang N; Mengersen K; Tong S; Kimlin M; Zhou M; Hu W
Cancer; 2020 Sep; 126(18):4220-4234. PubMed ID: 32648980
[TBL] [Abstract][Full Text] [Related]
18. [Trends in the mortality of liver cancer in Qidong, China: an analysis of fifty years].
Chen JG; Zhu J; Zhang YH; Chen YS; Ding LL; Lu JH; Zhu YR
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):532-7. PubMed ID: 22967473
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990-2017: A Joinpoint and Age-Period-Cohort Analysis.
Wang F; Mubarik S; Zhang Y; Wang L; Wang Y; Yu C; Li H
Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31408961
[TBL] [Abstract][Full Text] [Related]
20. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China.
Liu X; Yu C; Bi Y; Zhang ZJ
Public Health; 2019 Jul; 172():70-80. PubMed ID: 31220754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
